IMS Country Review: UK
IMS Health, July 2007, Pages: 50
IMS Health’s Country Profiles provide a comprehensive insight into the national sales of the pharmaceutical market in selected countries over 5 years. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company’s business strategy. Sales performance is analysed in terms of geographic region, major corporations, therapeutic classes, major products and new product activity.
All data is available over a 5 year period for easy trend analysis and is based on Quarter 4 sales figures.
Products Mentioned:
Coversyl
Cozaar
Efexor
Enbrel
Lipitor
Plavix
Seretide
Spiriva
Symbicort
Zyprexa
IMS:
Data Values and Definitions
Channels of Distribution
Audited Market Trend
Leading Companies – Top 35
Leading Corporations – Top 35
Fastest Growing Companies
Market Share By Corporate Nationality
15 Largest Therapeutic Classes
15 Fastest-Growing 3rd And 4th Level Therapeutic Classes
Therapeutic Class Profile
Leading Products – Top 40
Leading New Products – Top 40
Forms Most Commonly Used – Top 15
Pfizer
Astrazeneca
Allen & Hanburys
Wyeth Pharm
Roche Products
Novartis Pharm Uk
Aventis Pharma
Merck Sharp Dohme
Lilly
Pharmacia&Upjohn
Sanofi Bms
Janssen Cilag
Boehringer Ingelhm
Novo Nordisk Pharm
Schering Plough
Schering Hc
Abbott
Servier
Smithkline Beech
Glaxosmithklin Con
Bristol Myers Sqb
Ivax Pharm Uk
Napp
Glaxo Labs
Procter&Gamble Phm
Pfizer Consumer
Sanofi Winthrop
Eisai
Roche Diagnostics
Glaxo Wellcome
Shire Pharm
Sandoz
Astellas
Gilead Sciences
Baxter Healthcare
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
